Actieve functies van Naresh K. Nayyar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TURG POIN | Algemeen Adviseur | 01-06-2018 | - |
Loopbaan van Naresh K. Nayyar
Eerdere bekende functies van Naresh K. Nayyar
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01-04-2016 | 01-05-2018 |
Opleiding van Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| India | 2 |
Operationeel
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Naresh K. Nayyar
- Ervaring
